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A B S T R A C T
Integrative management of wildlife and livestock requires a clear understanding of the diseases trans-
mitted between the two populations. The tick-borne protozoan parasite Theileria parva causes two distinct
diseases in cattle, East Coast fever and Corridor disease, following infection with parasites derived from
cattle or buffalo, respectively. In this study, cattle were immunized with a live sporozoite vaccine con-
taining three T. parva isolates (the Muguga cocktail), which has been used extensively and successfully
in the ﬁeld to protect against cattle-derived T. parva infection. The cattle were exposed in a natural ﬁeld
challenge site containing buffalo but no other cattle. The vaccine had no effect on the survival outcome
in vaccinated animals compared to unvaccinated controls: nine out of the 12 cattle in each group suc-
cumbed to T. parva infection. The vaccine also had no effect on the clinical course of the disease. A
combination of clinical and post mortem observations and laboratory analyses conﬁrmed that the animals
died of Corridor disease. The results clearly indicate that the Muguga cocktail vaccine does not provide
protection against buffalo-derived T. parva at this site and highlight the need to evaluate the impact of
the composition of challenge T. parva populations on vaccine success in areas where buffalo and cattle
are present.
© 2015 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
For many African countries, maintaining wildlife populations is
important as a source of tourism revenue and as an integral part
of global biodiversity conservation (Wambwa, 2005; Thomson et al.,
2013). However, sustainable increases in livestock productivity are
seen as essential to the economic and social development of rural
Africa. These two activities are often in conﬂict and modern con-
servation efforts are aimed at integrative management of wildlife
and livestock. These efforts are constrained by competition for feed,
land and water resources, and by the presence of pathogens that
can be transmitted between the populations (Grootenhuis and
Olubayo, 1993). Although isolation of livestock and wildlife through
fences has been used to limit disease transmission, this approach
is not practical in extensive pastoral farming systems and has det-
rimental consequences through the resultant segregation of wildlife
sub-populations. The development of more effective control methods
for wildlife-derived livestock diseases is required. Essential to this
is a better understanding of the interaction between the patho-
gens, mammalian hosts and the vectors that transmit disease. This
will enable the implementation of strategies where wildlife and live-
stock can cohabit with minimal adverse impact on both.
In eastern, central and southern Africa, a disease of major in-
terest in this context is caused by infection with Theileria parva, an
apicomplexan protozoan parasite which is transmitted by the brown
ear tick (Rhipicephalus appendiculatus). T. parva infects both cattle
and the African buffalo (Syncerus caffer), although it is believed that
the parasite evolved with the buffalo in eastern Africa long before
the introduction of cattle (Uilenberg, 1981; Young, 1981). There are
very few, if any, clinical signs in infected buffalo, whereas in cattle
the parasite causes a severe, often fatal, lymphoproliferative
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disorder called East Coast fever (ECF). ECF results in considerable
economic losses as a consequence of high mortality rates and the
inability of livestock owners to introduce the more productive but
highly susceptible European breeds of cattle into enzootic areas
(Conelly, 1998).
Of particular importance in understanding the interaction
between T. parva, its tick vector and mammalian hosts is the dif-
ference between the buffalo- and cattle-maintained populations of
T. parva, in their biological properties and genotypic diversity. In-
fection of cattle with buffalo-derived parasites results in Corridor
disease (CD), which is characterized by low levels of parasitized leu-
kocytes in peripheral lymph nodes compared to the high parasitosis
seen in ECF (Neitz et al., 1955; Barnett and Brocklesby, 1966). Results
based on monoclonal antibody proﬁles and comparison of the se-
quences of known T. parva antigens have shown that parasites
derived from buffalo are muchmore heterogeneous than those from
cattle (Conrad et al., 1987; Grootenhuis and Olubayo, 1993; Pellé
et al., 2011). This may be because only a subset of parasite strains
from the more heterogeneous buffalo-maintained T. parva popula-
tion have crossed into cattle populations since the relatively recent
introduction of cattle into eastern Africa (Hanotte et al., 2002).
The functional signiﬁcance of the heterogeneity seen in T. parva
and whether it confers any selective advantage, during either the
mammalian or tick stages of the parasite life cycle, are unclear.
However, there is evidence that this diversity has an important in-
ﬂuence on immunity. The immunity induced by T. parva infection
is strong and long-lasting and has been extensively studied in the
bovine host. The principal mediators of the protective immune re-
sponse are CD8+ cytotoxic T lymphocytes (CTL) and several antigens
recognized by CTL have been identiﬁed and characterized (Graham
et al., 2006). Extensive polymorphism has been observed in three
of the known antigens Tp1, Tp2 (Pellé et al., 2011) and Tp9 (Sitt and
Pellé, unpublished observations), and natural variants of known CTL
epitopes can escape CTL recognition (MacHugh et al., 2009; Connelley
et al., 2011). These ﬁndings support the view that strain speciﬁc-
ity is due to antigenic differences between the immunizing and
challenge parasites.
The strong immunity following T. parva infection provides the
basis for a commercial vaccination procedure against ECF using live
parasites, called the Infection and Treatment Method (ITM) (Radley
et al., 1975a). Vaccination involves inoculation of cattle with spo-
rozoites in the form of a ground homogenate of infected ticks and
simultaneous administration of a long-acting formulation of oxy-
tetracycline to prevent the infection progressing to fatal disease.
Cross-immunity studies conducted in Kenya in the 1970s showed
that immunity is strain-speciﬁc, as cattle immunized against one
strain of the parasite are not necessarily protected against chal-
lenge with heterologous parasite strains (Radley et al., 1975a). The
studies undertaken during the development of the method showed
that immunization with a combination of three parasite isolates pro-
vided much broader protection than single isolates (Radley et al.,
1975b). This combination of parasite isolates, termed the Muguga
cocktail, is now the most widely used formulation for ITM vacci-
nation. It has been shown to reduce the incidence of ECF in ﬁeld
situations where cattle predominate, including parts of Kenya,
Uganda, Zambia, Tanzania and Malawi (Uilenberg et al., 1977;
Morzaria et al., 2000).
Previous experiments with other versions of the ITM vaccine have
shown that they do not always provide complete protection under
ﬁeld conditions (Snodgrass et al., 1972; Cunningham et al., 1974).
A number of cross-immunity studies have been conducted using
different cattle-derived T. parva stabilates, including locally derived
parasites, which have shown mixed results in development of pro-
tective immunity (Hove et al., 1996; Musisi et al., 1996; Latif et al.,
2001a). In particular, studies using the Muguga cocktail have indi-
cated that vaccination provided partial protection against challenge
with buffalo-derived T. parva (Radley et al., 1979). However, these
studies used tick stabilates delivered by needle inoculation or tick
challenge in a paddock artiﬁcially seeded with buffalo-derived para-
sites and on which other groups of cattle had grazed.
Although the Muguga cocktail has been deployed in areas where
both buffalo and cattle are present, it has not been tested in natural
ﬁeld situations where challenge arises solely from buffalo-derived
parasites. The purpose of this study was to address this question
bymonitoring groups of vaccinated and control (unvaccinated) calves
introduced into a T. parva-endemic area grazed only by buffalo and
other wildlife. The results were expected to have implications on
the use of the vaccine in areas where cattle co-graze with buffalo.
2. Materials and methods
2.1. Animal care and use
The study protocol was approved by ILRI’s Institutional Animal
Care and Use Committee (References 2011–11 and 2013–03).
The humane end-point was deﬁned as 10 days of elevated temper-
ature or if the animal developed severe signs of disease. Sampling
of buffalo was approved by the Kenya Wildlife Service
(KWS/BRM/5001).
2.2. Study site
The studywas undertaken on the Ol Pejeta Conservancy in Kenya,
which is revolutionizing efforts in integrative management of wild-
life and livestock (OPC, 2015). The ﬁeld site was located at the
southern end of the Ol Pejeta Conservancy, Nanyuki, Kenya
(00°03.052′S, 36°52.302′E; altitude 1784m) and comprised a fenced
area of about 500 hectares containing buffalo but not cattle. An
attempt at maintaining cattle in the area a number of years previ-
ously resulted in extremely high mortality due to suspected CD and
any surviving cattle were moved out of the location immediately.
2.3. Study animals
Twenty-four castrated male Boran calves, between the ages of
7 and 12 months, were obtained from the ILRI ranch, Kapiti, Kenya.
Prior to selection for the study, the animals were screened by
antibody-capture ELISA (Katende et al., 1998) and found to be neg-
ative for antibodies against T. parva. Animals were also tested by PCR
for the presence of T. parva using a nested PCR based on the p67
gene as will be described in 2.11, below. The calves were relocated
to the ILRI farm, Nairobi, and held in a tick-free environment for
2–4 weeks prior to vaccination. On arrival at ILRI, the calves were
treated with acaricide, an anthelminthic (Levamisole with cobalt;
Coopers K. Brands) and Imizol (Coopers K. Brands), and vacci-
nated against FMD (Kenya Veterinary Vaccines Production Institute).
Blood samples were collected from eight African buffalo at dif-
ferent locations on Ol Pejeta, but not within the study site due to
the thick vegetation present there. The locations were between 9
and 13 km from the study area. The buffalo were chemically re-
strained using a combination of etorphine and xylazine mixed in
a single dart and delivered using a Danject dart gun, according to
standard KenyaWildlife Service protocols. The animals were placed
in sternal recumbency and blood was drawn from the jugular
vein into EDTA and plain vacuum tubes (BD), stored in a cool
box and transported to the ﬁeld laboratory for processing. All animals
were sampled within 5 minutes of recumbency and revived using
appropriate dosages of a combination of atipamazole and
diprenorphine.
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2.4. Vaccination
Animals were randomly allocated into two groups of 12, vacci-
nated or control (unvaccinated), using a random number generator
in Excel. Animals were vaccinated by ITM with the ILRI 0801 batch
(Patel et al., 2011) of the Muguga cocktail vaccine. Each vacci-
nated animal received 1 ml of a 1:100 dilution of the vaccine and
30 mg/kg long-acting oxytetracycline (Alamycin LA 300, Norbrook
Laboratories). Control animals received 1 ml of vaccine diluent and
oxytetracycline.
2.5. Clinical reactions to vaccination
Calves were held in a tick-free environment for 40 days after vac-
cination during which time they were monitored daily for changes
in body temperature and observed for adverse reactions. Blood was
collected on a weekly basis into plain or EDTA tubes for serology
and parasite detection by p67 PCR, respectively. Lymph node (LN)
aspirates were obtained from the vaccinated animals from days 8
to 21 from the right parotid lymph node (LN) draining the site of
infection for detection of infected or hyperplastic cells.
2.6. Field study
On day 41 after vaccination and 6 days after their previous acari-
cide treatment, the calves were relocated from ILRI to the study site
after receiving a pre-shipment treatment of 15 mg/ml Betamox LA
andmultivitamins (Norbrook Laboratories). During the study period,
the calves were kept in a pen at night and allowed to graze freely
during the day. Ticks were allowed to attach naturally onto the calves
for the initial 10 days of ﬁeld challenge, thereafter, the animals were
treated with acaricide every 3–4 days. The study was ended 30 days
after introduction to the study site (71 days after vaccination), and
the surviving animals were incorporated into the Ol Pejeta herd.
Calf health was assessed every morning before the calves were
released for grazing. Key clinical parameters such as temperature,
respiration and LN swelling, were recorded daily. Field scientists were
blinded to the identity of the vaccinated and control groups.
2.7. Field sampling
Blood samples for serology and parasite detection were taken
from all calves at twice weekly intervals up to the detection of
pyrexia. Thereafter, samples were taken every other day until death
or the termination of the ﬁeld study on day 30. LN aspirates were
taken only from swollen parotid or pre-scapular nodes on every
second or third day depending on themicroscopy results and animal
health. For animals remaining after day 24 macroschizont posi-
tive LN were aspirated on a daily basis; to decrease LN damage, the
same lymph nodes were not necessarily sampled every day. If a LN
was negative two samplings in a row, after having been positive
macroschizont positive, it was no longer sampled.
2.8. Serology
Serumwas stored at −20 °C until use in ELISA. The samples were
analyzed in duplicate and the results are presented as percent posi-
tivity (PP) as previously described (Katende et al., 1998). Samples
with values of 20 PP or greater are considered positive for anti-
T. parva antibodies.
2.9. DNA extraction
Whole blood from the calves was aliquoted into cryovials and
kept at −20 °C for later DNA analysis. DNA extraction was con-
ducted on 200 μl of the frozen blood using High Pure PCR Template
Preparation Kit (Roche). Samples were eluted in 50 μl. The eluate
was run through the column twice to achieve a higher DNA con-
centration. DNA concentrationwasmeasured using a Nanodrop 1000
Spectrophotometer (Thermo-Scientiﬁc) and the DNA was stored at
−20 °C. Buffalo DNA was extracted from homogenized blood clots
from serum collection. DNA extraction was performed as earlier,
except that samples were eluted into 30 μl.
2.10. Microscopy
LN and blood smears were stained with Giemsa and examined
for the presence of parasites and hyperplastic cells.
2.11. PCR
The nested p67 PCRwas performed as described previously (Nene
et al., 1996) with the following modiﬁcations. The master mix con-
sisted of 2.5 μl of 10× FastStart PCR buffer (Roche), 2.5 μl 25 mM
MgCl2, 0.25 μl 25 mM dNTP, 0.25 μl each primer, 0.125 μl FastStart
Taq (Roche), 19.125 μl H2O and 2.5 μl (outer primer reaction) or 1 μl
(inner primer reaction) of DNA. The cycling conditions were 94 °C
for 5 min, 40 cycles (outer reaction) or 35 cycles (inner reaction)
of 95 °C for 1 min, 55 °C for 1 min, 74 °C for 1 min, 72 °C for 10 min
and a hold at 10 °C. PCR products were subjected to electrophore-
sis through a 1.5% agarose gel containing GelRed (Biotium) and
visualized under UV light. Both positive controls and negative (no
DNA) controls were included in each PCR.
2.12. Cloning and sequencing of p67 gene fragments
Fragments of the p67 gene from the last samples collected prior
to death or day 20–23 samples in survivors were generated by nested
PCR as follows. The master mix comprised 2.5 μl 10× PCR buffer,
0.16 μl 25 mM dNTPs, 0.25 μl primers, 0.25 μl PFU DNA Pol-
recombinant (Fermentas) and 21.34 μl H2O. Cycling conditions for
outer primers were 95 °C for 3 min, 40 cycles (outer reaction) or
30 cycles (inner reaction) of 95 °C for 45 s, 55 °C for 45 s, 72 °C for
5 min, 72 °C for 10 min and a hold at 10 °C. The PCR products were
puriﬁed using the HighPure PCR product puriﬁcation kit (Roche),
according to protocol. Ligation was conducted using the CloneJet
PCR Cloning kit (Thermo-Scientiﬁc), as instructed. Transformation
was conducted via standard heat shock protocol using DH5α cells.
Six positive clones were selected from each animal, and plasmid DNA
was prepared using a GeneJet MiniPrep kit (Thermo-Scientiﬁc) as
per manufacturer’s instructions. The presence of the desired plasmid
insert was conﬁrmed by gel electrophoresis. Sanger sequencing was
conducted on the cloned PCR products using the GeneAmp® 9700
system (Applied Biosystems). Sequence analysis and alignments were
conducted using Geneious version 6.0.6 created by Biomatters
(http://www.geneious.com).
2.13. Histology
Tissue samples from spleen, liver, lung and kidney were collect-
ed from nine calves (three vaccinated and six control) during post
mortem examination, and placed in phosphate-buffered formalin.
The tissues were processed by a local pathology laboratory (Aga Khan
University Hospital, Nairobi) and hematoxylin-and-eosin-stained his-
tological sections were prepared for microscopic examination.
2.14. Statistics
Statistics were conducted using GenStat (VSN-International,
2013). Survival analysis was conducted using Kaplan–Meier to eval-
uate the survival function of the two groups over time and a log-
rank test used to compare these survival curves. A non-parametric
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Fisher’s exact test was used to compare ﬁnal survival between the
two groups. To test for differences between vaccinated and control
groups in the onset and progress of disease (time to, and duration
of, pyrexia and LN parasitosis) a random permutation t-test equiv-
alent was used.
3. Results
3.1. Response to vaccination
As shown in Table 1, all but one of the vaccinated calves had
seroconverted by 35 days after vaccination, and all but one of the
vaccinated calves were positive by PCR on at least one sampling day
post vaccination. Microscopic examination of LN aspirates from the
right parotid lymph node between 8 and 21 days after vaccination
revealed varying degrees of hyperplasia in all vaccinated animals.
Macroschizonts were noted in only one animal (BJ047), between
11 and 13 days after vaccination. The control animals remained neg-
ative by ELISA and PCR. The results conﬁrm that the vaccinated cattle
were exposed to viable T. parva parasites, indicating that the animals
were successfully immunized.
3.2. Response to ﬁeld challenge
Ticks were observed to attach to the animals from day 2 of being
placed in the ﬁeld site. The majority of the ticks were identiﬁed as
R. appendiculatus.
The survival outcome of the challenge is summarized in Table 1.
Despite deﬁning clinical endpoints for treating the animals, the very
rapid progression of clinical symptoms in the later stages of infec-
tion resulted in death of many animals before treatment could be
implemented. Seventeen of the 24 animals died during the 30-
day ﬁeld exposure. An additional animal (BJ049), which was found
recumbent, received treatment with a theilericidal compound
(Buparvaquone) and survived; for the purposes of analyses of results,
this animal was considered to have suffered a fatal infection. Thus,
only six animals survived the challenge, of which three were vac-
cinates and three were controls. Clearly, there was no difference in
survival between the two groups (Fishers exact test, p = 1.000). The
time to death in the control and vaccinated groups is illustrated by
the Kaplan–Meier survival function in Fig. 1. There was no discern-
ible difference in the survival curves in the vaccinated and control
groups (N observed = 9 for both, N expected = 9.11, 8.89 for control
and vaccinated, respectively; log-rank test statistic = 0.001 on 1
degree of freedom, p = 0.953). The time of death appeared to be bi-
phasic: 15 animals (eight vaccinates and seven controls) died
between 20 and 22 days after exposure and three (one vaccinate
and two controls) died on day 27 or 28 after exposure. The ﬁnd-
ings demonstrate that vaccinationwith theMuguga cocktail provided
no protection against the ﬁeld challenge in this study.
3.3. Clinical signs
Brieﬂy, the clinical ﬁndings were typical of severe disease caused
by T. parva. The key signs observed included pyrexia, swollen parotid
and prescapular lymph nodes, labored breathing, nasal discharges,
lacrimation and corneal opacity, all of which indicate severe T. parva
infection.
3.4. Parasitology ﬁndings
Macroschizonts were observed in at least one LN of every animal
during the course of the study (Table 1). The macroschizonts were
ﬁrst detected between days 14 and 19 after exposure. In all animals
that died, macrochizonts remained detectable until death, whereas
Table 1
Clinical, parasitological and serological observations in vaccinated and control calves following immunization and ﬁeld exposure.a
Immunization Field challenge
Seroconv. p67b Pyrexia LN parasitosis Piroplasm p67b Seroconv. Death
Controls
2104 – – 14 (7) 14 (7) – + – 20
2150 – – 17 (5) 14 (8) – + – 22
2158 – – 20 (5) 15 (14) – + – 28
2253 – – 15 (4/2/1) 15 (8) – + – 22
2310 – – 14 (5/1/1) 14 (7) – + – 21
2325 – – 15 (7/2/4) 15 (13) 22 (7) + 20 28
2352 – – 15 (5) 15 (5) – + – 20
2381 – – 15 (4) 14 (7) – + – 20
2384 – – 16 (5) 15 (8) – + – 21
2124 (S)c – – 15 (8) 15 (10) – + 22 n/a
2166 (S) – – 18 (8) 16 (≥14) – + 24 n/a
2227 (S) – – 21 (1) 18 (3) 21 (2) + 19 n/a
Vaccinated
2170 28 + 15 (6) 15 (7) – + 11 21
2174 21 + 15 (6) 14 (7) – + – 20
2202 21 + 14 (7) 15 (6) – + – 21
2206 21 + 14 (7) 14 (7) – + – 21
2223 21 + 17 (8) 16 (8) – + – 27
2252 35 + 16 (1/1/4) 16 (5) – + 16 21
2265 – + 15 (7) 15 (8) – + – 22
2345 28 – 16 (3) 14 (7) – + – 21
2375 21 + 17 (5) 16 (5) – + – 22
2164 (S) 21 + 21 (6) 18 (≥11) – + – n/a
2317 (S) 21 + 20 (2) 17 (8) – + 9 n/a
2320 (S) 35 + 22 (3/1/3) 19 (10) – + 23 n/a
a All data, except for p67 results, are shown as days to ﬁrst occurrence following immunization or ﬁeld exposure. The numbers in brackets refer to the duration of pyrexia
and parasitosis. For pyrexia, brackets showing three ﬁgures indicate animals in which the pyrexic days (bold) were interrupted by days of normal temperature (italics).
b The p67analysis was undertaken on samples taken at day 28 after immunization (detection of parasite post vaccination) or on days 20–23 after ﬁeld exposure (survi-
vors), or on the ﬁnal sample before death (non-survivors).
c (S) indicates animals which survived.
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in four of the six surviving cattle, the number of macroschizonts
fell below the level of detection before the end of the experiment.
Microscopic examination of blood smears revealed the pres-
ence of piroplasms in only two calves. One surviving control calf
had a piroplasm level of <1/1000 on days 21 and 22 post expo-
sure. A second control calf had piroplasms for 7 days leading up its
death on day 28, increasing from <1/1000 on day 22 to 7% on day
28.
Blood from the last sample prior to death, or days 20–23 for sur-
vivors, from all control calves was analyzed by nested p67 PCR to
conﬁrm exposure to T. parva. All samples were positive, showing all
animals were infected with T. parva (Table 1).
Post mortem organ impression smears weremade from liver, lung
and spleen from 9 calves and also from kidney for three of the same
calves. Macroshizonts were seen in all kidney, lung and spleen im-
pression smears and in seven of the liver smears (results not shown).
3.5. Post mortem observations
Of the animals that died, 13 showed a conspicuous frothy white
exudate from the nasal cavities (Fig. 2A). Post mortem examina-
tions were performed on 11 calves. In all cases, there was extensive
pleural exudate (Fig. 2B) and in all cases that died between 20–22
days, there was also copious frothy exudate in the trachea (Fig. 2C).
None of the three calves that died on day 27 or 28 post exposure
had frothy exudate. These ﬁndings are consistent with previous ob-
servations on fatal T. parva infections.
3.6. Histology
Histological examination revealed generalized severe patholog-
ical changes in the spleen and lungs. Therewas extensive lymphocytic
depletion and disorganization of the splenic white pulp (typical of
T. parva infection) and also extensive cellular inﬁltration into the
interstitial spaces and to a more variable degree the alveolar septa
in the lung, often associated with edematous ﬂuid in the alveolar
spaces. The histological observations are consistent with severe
T. parva infection.
3.7. Serology
All three control animals that survived and one animal that died
showed evidence of an anti-T. parva antibody response, with
seroconversion occurring between days 19 and 24 after exposure
(Table 1). The remaining eight control animals that succumbed
showed no evidence of an anti-T. parva antibody response. These
included the calf (BJ049) that was treated and survived, although
this animal subsequently seroconverted after it had been removed
from the study. Immunized animals were considered to have ex-
perienced a restimulation of the antibody response if the antibody
titer value was 10 PP units greater than that immediately prior to
ﬁeld challenge. As shown in Table 1, four of the vaccinated calves
were restimulated, including two that survived the ﬁeld chal-
lenge. The median time to seroconversion after ﬁeld exposure for
the controls (21 days) was the same as that following the immu-
nization of the vaccinated group by ITM (21 days). On the other hand,
the median time to increased antibody levels for the vaccinated
animals after ﬁeld exposure was only 13.5 days. The results are con-
sistent with exposure of the animals to infection with T. parva soon
after their introduction into the ﬁeld. The more rapid response in
the vaccinated animals, compared to the controls, is indicative of
an anamnestic antibody response in these animals.
The serum taken from the last ﬁeld sample for each animal was
also examined for antibody to other blood pathogens. Three cattle
were positive for T. mutans, two for B. bigemina and none for
A. marginale (results not shown).
In summary, the results presented earlier support the view that
the animals died from infection with T. parva. More speciﬁcally, the
absence of piroplasms in most of the animals is typical of theile-
riosis caused by buffalo-derived T. parva (Neitz et al., 1955).
3.8. p67 sequence analysis
Previous studies of the p67 gene sequence in T. parva isolates have
identiﬁed a single allele in isolates derived from cattle residing in
buffalo-free areas, but several additional alleles in buffalo (Nene et al.,
1996; Sibeko et al., 2010). To obtain further evidence that the cattle
were infected with buffalo-derived parasites, the p67 gene se-
quences in the control cattle were compared to those obtained from
eight buffalo on the Ol Pejeta conservancy (Table 2). The se-
quences were grouped according to the presence or absence of two
indels of 129 bp and 174 bp (Sibeko et al., 2010). Type 1 lacks the
129 bp indel, type 2 has both, while type 3 lacks the 174 bp se-
quence. The results showed that the occurrence and distribution of
the sequence types was similar in the two populations. All three
types were found in both the cattle and buffalo populations, with
the two types previously found to be associated with buffalo (types
2 and 3) being the most common. Type 1, which is the only type
previously identiﬁed in cattle-maintained T. parva, was found only
in a single animal in each group. The results strongly suggest that
the cattle were infected with buffalo-derived parasites.
3.9. Effect of vaccination on disease development
Although vaccination did not affect the survival of cattle, it was
of interest to determine if vaccination affected the progress of the
disease by comparing various parameters associated with T. parva
infection. There was no statistically signiﬁcant difference between
the vaccinated and control cattle in the time to pyrexia (16.8 and
16.3 days, respectively; p = 0.602–0.626), the time to LN parasit-
osis (15.8 and 15.0 days, respectively; p = 0.245–0.261), the time from
initial pyrexia to death for non-survivors (6.3 and 6.8 days,
Fig. 1. Kaplan–Meier survival analysis. Kaplan–Meier survival analysis of vacci-
nated (dashed line) and control (solid line) calves following ﬁeld exposure. The black
circle and red cross at day 30 represent the animals remaining alive at the end of
the experiment (censored). (For interpretation of the references to color in this ﬁgure
legend, the reader is referred to the web version of this article.)
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respectively; p = 0.721–0.735) or the time from initial LN parasit-
osis to death for non-survivors (6.8 and 7.9 days, respectively;
p = 0.354–0.366). The results show that vaccination did not affect
the onset or progress of the disease.
4. Discussion
The results presented here show that the Muguga cocktail ITM
vaccine had no discernible protective effect in cattle in a ﬁeld sit-
uation where animals are exposed to ticks infected from buffalo.
Further, the vaccine appeared to have no effect on the progression
of the disease, with vaccinated animals dying and developing pyrexia
and parasitosis as rapidly as the unvaccinated animals.
Previous experimental studies of cattle vaccinated with the
Muguga cocktail have indicated that vaccination does not always
protect against challenge with T. parva isolated from buffalo (Radley
et al., 1979). The current study is the ﬁrst attempt to examine im-
munity in vaccinated cattle exposed to natural tick challenge in an
area where only the buffalo host is present. Intensive monitoring
of the animals during both vaccination and exposure, employing
parasitological, serological and molecular tools, failed to detect any
signiﬁcant differences between the responses in vaccinated and un-
vaccinated animals.
A 
 
 
B 
  
C 
  
Fig. 2. Post mortem examination. Post mortem examination for typical calves showing signs associated with Theileria infection. A: Copious frothy exudate from nasal cavi-
ties of BJ031 and BJ037. B: Pleural exudate in thoracic cavities of BJ033 and BJ041. C: Frothing in trachea of BJ026 and BJ033.
Table 2
Occurrence and distribution of p67 sequence types in control cattle and buffalo on
Ol Pejeta.
Type 1 Type 2 Type 3
Cattle
BJ024 +
BJ026 + +
BJ027 + +
BJ038 +
BJ041 +
BJ044 + +
BJ046 + +
BJ048 +
BJ049 +
BJ025 (S)a +
BJ029 (S) + +
BJ036 (S) +
Buffalo
301 +
302 +
303 + +
304 + +
305 +
306 + +
307 + +
308 + +
a (S) indicates animals which survived.
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The clinical observations together with post mortem and labo-
ratory results support the contention that calves in this study died
from infection with buffalo-derived T. parvamanifesting in CD. These
observations and signs include the lack of detectable piroplasm para-
sitemia in most animals, the history of the study site (lack of cattle),
and the similarities between the p67 alleles found in the cattle and
buffalo, including alleles previously only associated with buffalo. Pre-
vious studies have provided evidence that buffalo-derived parasites
are more antigenically diverse than those maintained in cattle (Pellé
et al., 2011). Hence, it is possible that the lack of immunity re-
ﬂects the greater antigenic heterogeneity in the challenge parasite
population. However, further work is required to conﬁrm whether
or not this is the case. In contrast to the high levels of schizont para-
sitosis in peripheral lymph nodes of cattle infected with cattle-
maintained T. parva (Barnett and Brocklesby, 1966), the levels of
schizonts are much lower in animals infected with buffalo-derived
parasites (Neitz et al., 1955). Nevertheless the terminal clinical symp-
toms, characterized by severe pulmonary edema, are very similar
and the histopathological observations in the lungs and spleens of
cattle that died in the current study exhibited similarities to those
seen in ECF. Hence, it is possible that cells infected with buffalo-
derived parasites preferentially migrate to internal organs.
The general lack of seroconversion in the control calves that died
is consistent with the results of a recently published ﬁeld study in
a buffalo-free area (Kiara et al., 2014) as well as a study assessing
cattle exposed to T. parva from buffalo (Mbizeni et al., 2013). This
is presumably due to the animals dying before an antibody re-
sponse has been generated, combined with generalized dysfunction
of the immune system as a consequence of pathology caused by the
infection. A novel observation in this study was that most of the
vaccinated animals that died also tended to show a lack of boost-
ing to the extant antibody response, again suggesting disruption of
immune function. The seroconversion observed in the animals that
survived conﬁrms that these animals were exposed to parasite chal-
lenge and that their survival was not due to the absence of infection.
Vaccination with the Muguga cocktail has been deployed suc-
cessfully in cattle in a number of countries in East Africa, including
areas where buffalo are present. The batch of the Muguga cocktail
vaccine used in the current study (the ILRI 08 batch) has shown
widespread eﬃcacy in the ﬁeld (unpublished observations). More-
over, a recent ﬁeld study in northern Tanzania suggested that there
is no difference in the eﬃcacy of the vaccine when used in areas
containing buffalo compared to those where buffalo were absent
(Homewood et al., 2006). However, there is currently no detailed
information on the antigenic diversity of the buffalo parasites in this
region or the proportion of the ticks that carry buffalo-derived para-
sites. If ticks carrying cattle-derived parasites predominate, most
vaccinated animals will initially be challengedwith parasites derived
from other cattle in the herd, which may allow the development
of a suﬃciently broad immunity to protect against subsequent ex-
posure to the buffalo parasites.
Within the Ol Pejeta conservancy, with the exception of the area
where the current study was conducted, cattle and buffalo co-
graze under an integrated wildlife/livestock management system.
Theileriosis caused by T. parva is themost important disease in cattle
within the conservancy, and has been controlled predominantly by
regular application of acaricides to prevent tick infestation. Recent
attempts to instigate an ECF immunization regime using theMuguga
cocktail have not been successful. Several vaccinated calves died from
apparent T. parva infection, when the routine 7-day acaricide ap-
plication interval was extended to 14 days. It is possible that the
tick control regime deployed on the conservancy has inﬂuenced the
nature of the parasite challenge by preferentially reducing the pop-
ulation of cattle-maintained T. parva, thus increasing the likelihood
that, upon initial exposure, cattle will be challenged with T. parva
parasites transmitted directly from buffalo.
5. Conclusion
The Muguga cocktail has been successfully implemented in
Northern Tanzania to protect against development of East coast fever
(cattle-derived T. parva) in cattle; at this study site in Kenya, the
vaccine does not protect against development of Corridor disease
(buffalo-derived T. parva) in cattle. Further knowledge of the mo-
lecular, antigenic and genetic differences between buffalo- and cattle-
derived T. parva populations is imperative to gain a more complete
understanding of the epidemiology and pathogenesis of the disease
and the development of better control tools, including vaccines. Such
control should aim to allow cattle to co-graze safely with cattle in
T. parva endemic areas, and provide an illustrative example of ad-
vancing the integrative management of livestock and wildlife.
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